Joyn Bio Stock
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
Sign up today and learn more about Joyn Bio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Joyn Bio Stock
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.
Funding History
| March 2018 | $100M |
|---|
Management
Co-Founder
Jason Kelly
Press
Forbes - May, 31 2019
This Company's GMOs Will Help Feed The World, Without Ever Being EatenGenetic Literacy Project - Jun, 5 2018
Can Joyn Bio's genetically engineered microbes replace chemical fertilizers?agprofessional.com - Mar, 21 2018
Partnership Joyn Bio to Reduce Negative Impact of Nitrogen FertilizerEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
